Voelcker Fund award supports innovative research

 

The Max and Minnie Tomerlin Voelcker Fund is awarding $1.8 million to UT Health San Antonio to support research projects conducted by promising early career researchers.

The Voelcker Fund’s Young Investigator Awards, which provide each recipient with $150,000 per year over three years ($450,000), are intended to support young scientists conducting biomedical research in the areas of cancer, heart disease, arthritis, muscular dystrophy, retinitis and/or macular degeneration of the retina.

To date, the Voelcker Fund has provided $29.4 million in grants for medical research to UT Health San Antonio.

This year’s Voelcker Fund Young Investigator Award recipients at UT Health San Antonio and their projects are as follows:

Evelien Bunnik, PhD, assistant professor in the Department of Microbiology, Immunology and Molecular Genetics.

Evelien Bunnik, PhD, assistant professor in the Department of Microbiology, Immunology and Molecular Genetics.

Project title: Characterizing atypical B cells as a therapeutic target in rheumatoid arthritis

 

 

 

 

 

 

Kevin Koronowski, PhD, assistant professor in the Department of Biochemistry and Structural Biology.

Kevin Koronowski, PhD, assistant professor in the Department of Biochemistry and Structural Biology with a joint appointment in the Sam and Ann Barshop Institute for Longevity and Aging Studies.

Project title: Molecular mechanisms linking circadian disruption with breast cancer

 

 

 

 

 

Elizabeth Wasmuth, PhD, assistant professor in the Department of Biochemistry and Structural Biology.

Elizabeth Wasmuth, PhD, assistant professor in the Department of Biochemistry and Structural Biology.

Project title: Uncovering therapeutic vulnerabilities in androgen receptor signaling

 

 

 

 

 

 

Shangang Zhao, PhD, assistant professor in the Department of Medicine, Division of Endocrinology.

Shangang Zhao, PhD, assistant professor in the Department of Medicine, Division of Endocrinology with a joint appointment in the Sam and Ann Barshop Institute for Longevity and Aging Studies.

Project title: Cardiovascular benefits of leptin lowering utilizing SGLT2 inhibition and a novel leptin antibody in heart disease



Share This Article!